Omega-3 Blood Levels and Stroke Risk: A Pooled and Harmonized Analysis of 183 291 Participants From 29 Prospective Studies.

atrial fibrillation cerebrovascular disease fish fish oil stroke

Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
Jan 2024
Historique:
medline: 22 12 2023
pubmed: 22 12 2023
entrez: 22 12 2023
Statut: ppublish

Résumé

The effect of marine omega-3 PUFAs on risk of stroke remains unclear. We investigated the associations between circulating and tissue omega-3 PUFA levels and incident stroke (total, ischemic, and hemorrhagic) in 29 international prospective cohorts. Each site conducted a de novo individual-level analysis using a prespecified analytical protocol with defined exposures, covariates, analytical methods, and outcomes; the harmonized data from the studies were then centrally pooled. Multivariable-adjusted HRs and 95% CIs across omega-3 PUFA quintiles were computed for each stroke outcome. Among 183 291 study participants, there were 10 561 total strokes, 8220 ischemic strokes, and 1142 hemorrhagic strokes recorded over a median of 14.3 years follow-up. For eicosapentaenoic acid, comparing quintile 5 (Q5, highest) with quintile 1 (Q1, lowest), total stroke incidence was 17% lower (HR, 0.83 [CI, 0.76-0.91]; Higher omega-3 PUFA levels are associated with lower risks of total and ischemic stroke but have no association with hemorrhagic stroke.

Sections du résumé

BACKGROUND UNASSIGNED
The effect of marine omega-3 PUFAs on risk of stroke remains unclear.
METHODS UNASSIGNED
We investigated the associations between circulating and tissue omega-3 PUFA levels and incident stroke (total, ischemic, and hemorrhagic) in 29 international prospective cohorts. Each site conducted a de novo individual-level analysis using a prespecified analytical protocol with defined exposures, covariates, analytical methods, and outcomes; the harmonized data from the studies were then centrally pooled. Multivariable-adjusted HRs and 95% CIs across omega-3 PUFA quintiles were computed for each stroke outcome.
RESULTS UNASSIGNED
Among 183 291 study participants, there were 10 561 total strokes, 8220 ischemic strokes, and 1142 hemorrhagic strokes recorded over a median of 14.3 years follow-up. For eicosapentaenoic acid, comparing quintile 5 (Q5, highest) with quintile 1 (Q1, lowest), total stroke incidence was 17% lower (HR, 0.83 [CI, 0.76-0.91];
CONCLUSIONS UNASSIGNED
Higher omega-3 PUFA levels are associated with lower risks of total and ischemic stroke but have no association with hemorrhagic stroke.

Identifiants

pubmed: 38134264
doi: 10.1161/STROKEAHA.123.044281
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

50-58

Auteurs

James H O'Keefe (JH)

Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City (J.H.O., E.L.O.).

Nathan L Tintle (NL)

Fatty Acid Research Institute (N.L.T., W.S.H., A.S.-V., J.W.), Sioux Falls, SD.

William S Harris (WS)

Fatty Acid Research Institute (N.L.T., W.S.H., A.S.-V., J.W.), Sioux Falls, SD.
University of South Dakota (W.S.H.), Sioux Falls, SD.

Evan L O'Keefe (EL)

Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City (J.H.O., E.L.O.).

Aleix Sala-Vila (A)

Fatty Acid Research Institute (N.L.T., W.S.H., A.S.-V., J.W.), Sioux Falls, SD.
Hospital del Mar Medical Research Institute, Barcelona, Spain (A.S.-V., I.L.).

John Attia (J)

The University of Newcastle, School of Biomedical Sciences and Pharmacy, Callaghan, Australia (J. Attia, G.M.G., A.H.).

G Manohar Garg (GM)

The University of Newcastle, School of Biomedical Sciences and Pharmacy, Callaghan, Australia (J. Attia, G.M.G., A.H.).

Alexis Hure (A)

The University of Newcastle, School of Biomedical Sciences and Pharmacy, Callaghan, Australia (J. Attia, G.M.G., A.H.).

Christian Sørensen Bork (CS)

Department of Cardiology, Aalborg University Hospital, Denmark (C.S.B.).

Erik Berg Schmidt (EB)

Department of Clinical Medicine (E.B.S.), Aalborg University Hospital, Denmark.

Stine Krogh Venø (SK)

Department of Clinical Biochemistry (S.K.V.), Aalborg University Hospital, Denmark.

Kuo-Liong Chien (KL)

National Taiwan University, Institute of Epidemiology and Preventive Medicine, Taipei (K.-L.C.).

Yun-Yu Amelia Chen (YA)

Department of Medical Research, Taichung Veterans General Hospital, Taiwan (Y.-Y.C.).

Sarah Egert (S)

Institute of Nutrition and Food Sciences and Nutritional Physiology, University of Bonn, Germany (S.E.).

Tobias Rudholm Feldreich (TR)

Dalarna University, School of Health and Welfare, Falun, Sweden (T.R.F.).

Johan Ärnlöv (J)

Division of Family Medicine and Primary Care, Department of Neurobiology Care Sciences and Society, Karolinska Institutet, Solna, Sweden (J. Ärnlöv).

Lars Lind (L)

Department of Medical Sciences Cardiovascular Epidemiology, Uppsala University, Sweden (L.L.).

Nita G Forouhi (NG)

MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, United Kingdom (N.G.F., F.I.).

Johanna M Geleijnse (JM)

Division of Human Nutrition and Health, Wageningen University and Research, the Netherlands (J.M.G., K.P.).

Kamalita Pertiwi (K)

Division of Human Nutrition and Health, Wageningen University and Research, the Netherlands (J.M.G., K.P.).

Fumiaki Imamura (F)

MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, United Kingdom (N.G.F., F.I.).

Vanessa de Mello Laaksonen (V)

Institute of Public Health and Clinical Nutrition (V.d.M.L., W.M.U., J.T., M.A.L., J.V.), School of Medicine, University of Eastern Finland, Kuopio, Finland.

W Matti Uusitupa (WM)

Institute of Public Health and Clinical Nutrition (V.d.M.L., W.M.U., J.T., M.A.L., J.V.), School of Medicine, University of Eastern Finland, Kuopio, Finland.

Jaakko Tuomilehto (J)

Institute of Public Health and Clinical Nutrition (V.d.M.L., W.M.U., J.T., M.A.L., J.V.), School of Medicine, University of Eastern Finland, Kuopio, Finland.

Markku Laakso (M)

Department of Internal Medicine (M.L.), School of Medicine, University of Eastern Finland, Kuopio, Finland.

Maria Anneli Lankinen (MA)

Institute of Public Health and Clinical Nutrition (V.d.M.L., W.M.U., J.T., M.A.L., J.V.), School of Medicine, University of Eastern Finland, Kuopio, Finland.

Danielle Laurin (D)

CHU de Québec-Université Laval and VITAM Research Centers, Centre d'Excellence sur le Vieillissement de Québec, Canada (D.L., P.-H.C.).

Pierre-Hugues Carmichael (PH)

CHU de Québec-Université Laval and VITAM Research Centers, Centre d'Excellence sur le Vieillissement de Québec, Canada (D.L., P.-H.C.).

Joan Lindsay (J)

School of Epidemiology and Public Health, University of Ottawa, Canada (J.L.).

Karin Leander (K)

Karolinska Institutet, Institute of Environmental Medicine, Unit of Cardiovascular and Nutritional Epidemiology, Stockholm, Sweden (K.L., F.L.).

Federica Laguzzi (F)

Karolinska Institutet, Institute of Environmental Medicine, Unit of Cardiovascular and Nutritional Epidemiology, Stockholm, Sweden (K.L., F.L.).

Brenton R Swenson (BR)

Cardiovascular Health Research Unit (B.R.S.), University of Washington, Seattle.

William T Longstreth (WT)

Departments of Neurology and Epidemiology (W.T.L.), University of Washington, Seattle.

JoAnn E Manson (JE)

Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, MA (J.E.M., S.M., N.R.C.).

Samia Mora (S)

Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, MA (J.E.M., S.M., N.R.C.).

Nancy R Cook (NR)

Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, MA (J.E.M., S.M., N.R.C.).

Matti Marklund (M)

The George Institute for Global Health, University of New South Wales, Newtown, Australia (M.M.).
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (M.M.).
Department of Public Health and Caring Sciences, Uppsala University, Sweden (M.M.).

Debora Melo van Lent (D)

Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas, San Antonio (D.M.v.L.).

Rachel Murphy (R)

Cancer Control Research, British Columbia Cancer, School of Population and Public Health, University of British Columbia, Vancouver, Canada (R.M.).

Vilmundur Gudnason (V)

Icelandic Heart Institute, Kopavogur, Iceland (V.G.).

Toshihara Ninomiya (T)

Department of Epidemiology and Public Health and Center for Cohort Studies, Kyushu University, Fukouka, Japan (T.N., Y.H.).

Yoichiro Hirakawa (Y)

Department of Epidemiology and Public Health and Center for Cohort Studies, Kyushu University, Fukouka, Japan (T.N., Y.H.).

Frank Qian (F)

Harvard Medical School, T.H. Chan School of Public Health and Beth Deaconess Medical Center, Boston, MA (F.Q.).

Qi Sun (Q)

Harvard Medical School, T.H. Chan School of Public Health and Channing Division of Network Medicine Brigham and Women's Hospital, Boston, MA (Q.S., F.H.).

Frank Hu (F)

Harvard Medical School, T.H. Chan School of Public Health and Channing Division of Network Medicine Brigham and Women's Hospital, Boston, MA (Q.S., F.H.).

Andres V Ardisson Korat (AV)

USDA Human Nutrition Research Center on Aging, Tufts University, Boston, MA (A.V.A.K.).

Ulf Risérus (U)

Department of Public Health and Caring Sciences Clinical Nutrition and Metabolism Unit, Uppsala University, Sweden (U.R.).

Iolanda Lázaro (I)

Hospital del Mar Medical Research Institute, Barcelona, Spain (A.S.-V., I.L.).

Cecilia Samieri (C)

Bordeaux Population Health Research Centre, University of Bordeaux, France (C.S., M.L.G., C.H.).

Mélanie Le Goff (M)

Bordeaux Population Health Research Centre, University of Bordeaux, France (C.S., M.L.G., C.H.).

Catherine Helmer (C)

Bordeaux Population Health Research Centre, University of Bordeaux, France (C.S., M.L.G., C.H.).

Marinka Steur (M)

Department of Epidemiology, University Medical Center Rotterdam, the Netherlands (M.S., T.V., M.K.I.).

Trudy Voortman (T)

Department of Epidemiology, University Medical Center Rotterdam, the Netherlands (M.S., T.V., M.K.I.).

M Kamran Ikram (MK)

Department of Epidemiology, University Medical Center Rotterdam, the Netherlands (M.S., T.V., M.K.I.).

Toshiko Tanaka (T)

National Institutes of Health, National Institute on Aging, Longitudinal Studies Section, Baltimore, MD (T.T., L.F.).

Jayanta K Das (JK)

Tata Medical Center, Kolkata, India (J.K.D.).

Luigi Ferrucci (L)

National Institutes of Health, National Institute on Aging, Longitudinal Studies Section, Baltimore, MD (T.T., L.F.).

Stefania Bandinelli (S)

Azienda Sanitaria Firenze, Geriatric Unit, Florence, Italy (S.B.).

Michael Tsai (M)

Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis (M.T.).

Weihua Guan (W)

Division of Biostatistics, University of Minnesota, Minneapolis (W.G.).

Parveen Garg (P)

Department of Medicine, Cardiology, University of Southern California, Los Angeles (P.G.).

W M Monique Verschuren (WMM)

National Institute for Public Health and the Environment Bilthoven, the Netherlands (W.M.M.V.).
Julius Center for Health Sciences and Primary Care and Centre for Nutrition, Prevention and Health Services, Utrecht, the Netherlands (W.M.M.V.).

Jolanda M A Boer (JMA)

National Institute for Public Health and the Environment Bilthoven, the Netherlands (J.M.A.B., A.B.).

Anneke Biokstra (A)

National Institute for Public Health and the Environment Bilthoven, the Netherlands (J.M.A.B., A.B.).

Jyrki Virtanen (J)

Institute of Public Health and Clinical Nutrition (V.d.M.L., W.M.U., J.T., M.A.L., J.V.), School of Medicine, University of Eastern Finland, Kuopio, Finland.

Michael Wagner (M)

Departments of Neurodegenerative Diseases and Geriatric Psychiatry and German Center for Neurodegenerative Diseases, University Hospital, Bonn, Germany (M.W.).

Jason Westra (J)

Fatty Acid Research Institute (N.L.T., W.S.H., A.S.-V., J.W.), Sioux Falls, SD.

Luc Albuisson (L)

University of Denver, CO (L.A.).

Kazumasa Yamagishi (K)

Department of Public Health Medicine, University of Tsukubu, Japan (K.Y.).

David S Siscovick (DS)

Department of Epidemiology, New York Academy of Medicine (D.S.S.).

Rozenn N Lemaitre (RN)

Department of Medicine, University of Washington, Seattle (R.N.L.).

Dariush Mozaffarian (D)

Division of Cardiology, Tufts University, Boston, MA (D.M.).

Classifications MeSH